Patents by Inventor Lisa Shinefeld

Lisa Shinefeld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220236265
    Abstract: The present disclosure provides methods and lateral flow devices for detecting a plurality of target analytes in a liquid sample. In some implementations, the disclosed lateral flow device comprises a housing unit, a capillary flow bed, a sample-receiving zone, a buffer-receiving zone, and a capture zone. The device is configured to control the flow of the sample and reagent buffer in a sequential manner with minimal mixing. In some implementations, the disclosed method is capable of detecting a plurality of target analytes in an assay by applying the binding agents and the signaling agents in separate or sequential steps.
    Type: Application
    Filed: April 4, 2022
    Publication date: July 28, 2022
    Inventors: Gregory M. Lawrence, Adam P. Lousararian, Yli Remo Vallejo, Lisa Shinefeld
  • Patent number: 11293922
    Abstract: The present disclosure provides methods and lateral flow devices for detecting a plurality of target analytes in a liquid sample. In some implementations, the disclosed lateral flow device comprises a housing unit, a capillary flow bed, a sample-receiving zone, a buffer-receiving zone, and a capture zone. The device is configured to control the flow of the sample and reagent buffer in a sequential manner with minimal mixing. In some implementations, the disclosed method is capable of detecting a plurality of target analytes in an assay by applying the binding agents and the signaling agents in separate or sequential steps.
    Type: Grant
    Filed: July 27, 2018
    Date of Patent: April 5, 2022
    Assignee: Verax Biomedical Incorporated
    Inventors: Yli Remo Vallejo, Gregory M. Lawrence, Adam P. Lousararian, Lisa Shinefeld
  • Publication number: 20190079085
    Abstract: The present disclosure provides methods and lateral flow devices for detecting a plurality of target analytes in a liquid sample. In some implementations, the disclosed lateral flow device comprises a housing unit, a capillary flow bed, a sample-receiving zone, a buffer-receiving zone, and a capture zone. The device is configured to control the flow of the sample and reagent buffer in a sequential manner with minimal mixing. In some implementations, the disclosed method is capable of detecting a plurality of target analytes in an assay by applying the binding agents and the signaling agents in separate or sequential steps.
    Type: Application
    Filed: July 27, 2018
    Publication date: March 14, 2019
    Inventors: Gregory M. Lawrence, Yli Remo Vallejo, Adam P. Lousararian, Lisa Shinefeld
  • Patent number: 9643180
    Abstract: The invention provides an improved method for sensitive and specific detection of target molecules, cells, or viruses. The inventive method uses large area imaging to detect individual labeled targets complexed with a target-specific selection moiety. The invention eliminates wash steps through the use of target-specific selection through one or more liquid layers that can contain optical dye and density agents. By eliminating washes the invention simplifies instrumentation engineering and minimizes user steps and costs. The invention uses sensitive image analysis to enumerate individual targets in a large area, is scalable, and can be deployed in systems ranging in complexity from manual to highly automated.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: May 9, 2017
    Assignee: First Light Biosciences, Inc.
    Inventors: Ezra Abrams, Sadanand Gite, Lisa Shinefeld, Don Straus, Gordon Siek, Greg Yantz
  • Publication number: 20160011185
    Abstract: The present invention is directed to devices and methods using pan-generic antibodies to detect bacteria in a sample. The invention relates to binding assays, especially immunoassays, utilizing a multivalent binding agent immobilized on a particle. The invention also relates to the surprising discovery that increasing the size of the particles improves the sensitivity of the screen.
    Type: Application
    Filed: March 4, 2014
    Publication date: January 14, 2016
    Inventors: Gregory M. Lawrence, Lisa Shinefeld
  • Publication number: 20150241424
    Abstract: The present invention is directed to devices and methods using pan-generic antibodies to detect bacteria in a sample.
    Type: Application
    Filed: October 7, 2013
    Publication date: August 27, 2015
    Inventors: Gregory M. Lawrence, Lisa Shinefeld
  • Publication number: 20120149007
    Abstract: The invention provides an improved method for sensitive and specific detection of target molecules, cells, or viruses. The inventive method uses large area imaging to detect individual labeled targets complexed with a target-specific selection moiety. The invention eliminates wash steps through the use of target-specific selection through one or more liquid layers that can contain optical dye and density agents. By eliminating washes the invention simplifies instrumentation engineering and minimizes user steps and costs. The invention uses sensitive image analysis to enumerate individual targets in a large area, is scalable, and can be deployed in systems ranging in complexity from manual to highly automated.
    Type: Application
    Filed: September 24, 2009
    Publication date: June 14, 2012
    Applicant: Straus Holdings Inc.
    Inventors: Ezra Abrams, Sadanand Gite, Lisa Shinefeld, Don Straus, Gordon Siek, Greg Yantz
  • Patent number: 5145784
    Abstract: A capillary flow device useful in double capture assays, such as double capture immunoassays, and a double capture assay. The capillary flow device comprises a capillary track, a sample receptacle, a particle collecting means and, optionally, a magnet and a particle concentrator. The assay method is useful for determining any analyte of interest for which there is a specific binding partner.
    Type: Grant
    Filed: January 2, 1992
    Date of Patent: September 8, 1992
    Assignee: Cambridge Biotech Corporation
    Inventors: Daniel E. Cox, Obsidiana Abril, Sara Bauminger, Bruce P. Neri, Lisa Shinefeld